Diabetes treatment > Access and supply

English

Children and diabetes: success and challenge in the developing world

Graham Ogle, Angie Middlehurst and Robyn Short-Hobbs

Good things come in pairs: the Cambodia-Korea Twinning Project

Professor Bong Yun Cha, Chairman of the Korean Diabetes Association and Dr. Touch Khun, Chief of Diabetology at the Preah Kossamak Hospital in Phnom Penh, Cambodia report on the exciting partnership reflected in the IDF’s Association Twinning Initiative. Learn how people living with diabetes in Cambodia are getting extra help for better care by virtue of the first and more significantly, the second, Cambodia-Korea Twinning Project.


Insulin for Life – building capacity, saving lives

Insulin is a life-sustaining medication, designated an essential drug by the World Health Organization. Although it should be universally available to everyone who requires it for survival, in many countries access to insulin is not secure – resulting in life-threatening complications for large numbers of children and adults with diabetes worldwide. Indeed, most people in most countries of the world who need life-saving insulin cannot obtain it.

Ninety years of insulin - Canada celebrates

The discovery of insulin in 1921 is undoubtedly one of the most significant medical discoveries of the 20th century. Frederick Banting is considered as the main discoverer since he was the one who had the idea of tying a ligature round the pancreatic canals in order to provoke diabetes. when he was still a young surgeon in London, ontario (Canada), he met JJR Macleod of the University of Toronto and suggested experimenting with this procedure in dogs.

Translating evidence into practice: improving access to HbA1c in sub-Saharan Africa

The use of HbA1c is becoming mandatory for good-standard diabetes care thanks to scientific evidence generated over the past two decades worldwide. HbA1c as a reflection of chronic hyperglycaemia is also becoming a key indicator increasingly used for the diagnosis of diabetes. however, underserved populations in poor countries have little awareness of or access to this important diagnostic and monitoring tool.

Against the worldwide epidemic

Editor-in-chief's editorial

Promoting foot care education in developing countries: the Caribbean Diabetic Foot Care Programme

There are 285 million people living with diabetes worldwide, the number of affected people is predicted to reach 438 million by 2030. Because of the rapid increase in diabetes prevalence, the number of diabetes complications is rising equally quickly. Amputation is one of the most feared of these complications. People with diabetes are at risk for nerve damage and problems with the supply of blood to their feet. Nerve damage results in a reduced ability to feel pain and, as a consequence, injuries often go unnoticed. Moreover, poor blood supply can slow down the process of wound healing.


Access to insulin and barriers to care: results of the RAPIA in Vietnam

Access to diabetes care in many countries is problematic due to a variety of factors. These can range from the cost of medication to the distance that people with diabetes need to travel to access a trained healthcare provider. Without adequate access to medication and care, people with diabetes face complications and early death. The authors report on an evaluation of the provision of care and supplies for people with diabetes in Vietnam.

 


Improving access to education and care in Cambodia

Four years ago, when Cambodia’s first diabetes surveys were analysed, they surprised everyone: there were twice as many people with diabetes than had been expected – more than 250,000 people. However, the major donors supporting the country’s healthcare sector continue to distribute financial support in unequal shares.

Social injustice and unmet needs: women and diabetes in the Americas

Diabetes has become an important cause of death and disability in the Americas and worldwide. In the region comprising South America, Central America and the Caribbean, and North America, the number of people with diabetes is expected to rise from 13 million to 33 million by 2030. An even more marked increase is set to occur in Latin America and the Caribbean, where most of the nations are considered to be developing countries. This rising prevalence of diabetes is already having grave effects on societies, and women throughout the continent are baring the brunt of the pandemic.

Pages